MedPath

菲洋生物科技(吉林)有限公司

Ownership
-
Established
2016-10-20
Employees
-
Market Cap
-
Website
www.feiyangjl.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

NMPA:2

Drug Approvals

Alendronate Sodium Tablets

Product Name
阿仑膦酸钠片
Approval Number
国药准字H20253811
Approval Date
Apr 8, 2025
NMPA

Denosumab Injection

Product Name
恒盖
Approval Number
国药准字S20240039
Approval Date
Sep 3, 2024
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.